moderna mrna vaccine - Search News

Order byBest matchMost fresh

Moderna, COVID-19

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a monovalent JN.1 lineage, with a preference for the LP.8.1 variant.

· 10h

· 15h · on MSN

Moderna files application for updated COVID vaccine

· 11h · on MSN

Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 1d

· 8h

Uncertainty loomed as FDA advisors met to discuss this year’s COVID shot

Arizona PBS · 18h

FDA ends routine COVID shots for healthy young Americans

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 20h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

19hon MSN

Officials have been questioning safety, efficacy of mRNA vaccines. What we know

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

STAT2d

How do we know mRNA vaccines are safe and effective? An explainer

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

MPR1d

Moderna Withdraws BLA for Flu/COVID-19 Combo Vaccine Candidate

Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after

Live Science on MSN4d

2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.

Vietnam Investment Review on MSN5d

AIM Vaccine's Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine Through

While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today that its self-developed mRNA shingles vaccine has received clinical trial approval from PRC's Center for Drug Evaluation (CDE),